drugset / Trial / NCT04418739

Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes

NCT04418739

Phase 2 Unknown 122 enrolled Universiti Kebangsaan Malaysia Medical Centre
RandomizedParallel-groupSingle-blindPrevention

Summary

Pancreaticoduodenectomy (PD), more commonly known as Whipple's surgery is the mainstay treatment for pancreatic head and periampullary cancer. Factors contributing to PD outcomes are broadly categorized to disease-related, patient-related and operative factors. Whereas an inexhaustible list of study exists on looking at reducing PD complication rates with respect to the above-mentioned factors, it was only recently that more attention has been given to the impact of perioperative and intraoperative fluid regimes on PD outcomes. This study takes interest in the impact of intraoperative fluid regimes on PD outcomes. The objective of this investigation is to compare the outcomes with the use of intraoperative intravenous human albumin versus standard intraoperative fluid regimes.

Timeline

Start
2020-01-27
Primary completion
2022-11-26
Completion
2022-11-26

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic 1 g/kg Intravenous